Thermo Fisher Scientific Specialty Diagnostics — Segment assets increased by 1.2% to $1.32B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.6%, from $1.22B to $1.32B.
An increase may indicate capital expansion or investment in growth, while a decrease could signal asset divestment or improved capital efficiency.
This metric represents the total book value of assets specifically allocated to the Specialty Diagnostics operating segm...
Comparable to segment-specific asset bases reported by life science and diagnostic peers like Danaher or Abbott Laboratories.
tmo_segment_specialty_diagnostics_segment_assets| Q4 '23 | Q3 '24 | Q4 '24 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $1.15B | $1.23B | $1.22B | $1.31B | $1.32B |
| QoQ Change | — | +7.3% | -1.3% | +7.3% | +1.2% |
| YoY Change | — | — | +5.9% | +5.9% | +8.6% |
We use cookies for analytics. See our Privacy and Cookie Policy.